Science & Research
Information about FDA's National Center for Toxicological Research (NCTR), pediatrics, clinical trials, foods and veterinary medicine research, and more.
Clinical Trials and Human Subject Protection
Guidances, Information Sheets, Notices and more.
Learn MoreNavigate the Science & Research Section
About Science & Research at FDA
An overview of science and research projects across the various components of FDA.
Field Science and Laboratories
ORA Laboratory Profiles, Laboratory Manual, Laboratory Information Bulletins, Policy for consumer product tests, training laboratory staff, report writing, private laboratory report reviews, and testimony.
FDA STEM Education, Engagement, and Outreach
FDA STEM activities support FDA efforts to continue attracting and developing highly skilled scientists.
Science and Research Special Topics
Women's health, pediatrics, the Critical Path Initiative, nanotechnology, clinical trials, and peer reviews of scientific information.
More in the Science & Research Section
Bioinformatics Tools
Tools for analyzing and integrating genomics, transcriptomics, proteomics, and metabolomics datasets.
Data Mining at FDA
Information on data mining initiatives at FDA.
Health Informatics at FDA
Overview of FDA’s health informatics initiatives to optimize acquisition, storage, retrieval, and use of information in public health and biomedicine.
Meetings, Conferences, and Workshops
FDA science-related gatherings, including the Science Forum, Science Writers Symposium, and public science meetings.
More in the Science & Research Section
Science & Research Programs at FDA
Office of the Chief Scientist
The Office of the Chief Scientist provides strategic leadership, coordination, and expertise, supporting scientific excellence, innovation and capacity to achieve FDA's public health mission.
National Center for Toxicological Research (NCTR)
The National Center for Toxicological Research conducts scientific research to generate data for FDA decision making, and develops and supports innovative tools and approaches that FDA uses to protect and promote public health.
Oncology Center of Excellence
The Oncology Center of Excellence will help expedite the development of oncology and hematology medical products and support an integrated approach in the clinical evaluation of drugs, biologics, and devices for the treatment of cancer.
Research at FDA
Drugs
Research by FDA Staff to evaluate and enhance the efficacy, safety, and quality of drug products.
Medical Devices
Laboratory and field research in the areas of physical, life, and engineering sciences as well as epidemiological research in postmarket device safety
Food
Biotechnology, laboratory methods and publications, research strategic plan, and research areas such as risk assessment and consumer behavior.
More Research at FDA
Biologics
Research by FDA staff to evaluate and enhance the safety of biologic products.
Toxicological Research
Bioinformatics, biostatistics, computational toxicology, food protection, imaging, and nanotechnology.
Animal & Veterinary
Research activities that support the needs of FDA’s animal health regulators, on issues including pre-market drug review, compliance, post-approval monitoring, and animal feed safety.
More Research at FDA
More Science & Research Programs at FDA
Nanotechnology Programs at FDA
FDA staff are involved in many activities intended to build regulatory science knowledge, facilitate collaborations and partnerships with stakeholders, and establish a flexible, product-focused, science-based approach to regulation of products that involve nanomaterials or applications of nanotechnology.
Field Science - Laboratory Manual
The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and court testimony.
Advancing Regulatory Science
FDA's Advancing Regulatory Science Initiative builds on the achievements of existing Agency programs, like the Critical Path Initiative's groundbreaking efforts to transform the way medical products are developed, evaluated, and manufactured.